Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

A breakthrough technique that can help measure the brain proteins that trigger Alzheimer's disease, could also lead to ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million in 2024. This growth is poised to accelerate, with the market projected to ...

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer ...

Pearsanta, a subsidiary of Aditxt, has commenced enrolment in a clinical trial to assess the blood-based Mitomic ...

Biostate AI, a pioneer in AI-driven molecular diagnostics, today announced that its Indian subsidiary Bayosthiti AI has partnered with Narayana Health, one of the world's largest cardiac care networks ...

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.

A quick, purification-free method was developed by researchers at Institute of Science Tokyo, to capture the detailed 3D structures of flexible sugar ...

Curve Biosciences, the Whole-Body Intelligencetm company, today announced it has raised $40 million in funding led by Luma Group with participation from First Spark Ventures, Techas Capital, Micah ...